Home | About Us | Our Products | Our Facilites | Quality Assurance | Feed Back | Contact Us
 

5th May 2009
Dolphin has added seven more formulations to its growing Sri Lanka Portfolio

28th April 2009
The Board of Directors of the Company in its 154th meeting held on Tuesday, 28 April, 2009 has recommended 50% cash and 25% stock dividend (bonus share)

Metformin HCL Tablet
Back
 a) Generic Name

Metformin hydrochloride USP

 b) Trade/Brand Name

To be submitted at the time of inclusion.

 a) Presentation

Tablet (Film Coated).
Each tablet contains Metformin hydrochloride USP 850 mg.

 b) Indications

Type-II diabetes (non-insulin dependent diabetes); Type-I diabetes (insulin dependent diabetes) as adjuvant therapy in combination with insulin; obesity and insulin resistance; hyperlipoproteinemia.

 c) Dosage & administration

Treatment is usually initiated with 500-1000 mg daily, followed by a gradual increase if necessary. No further effect on blood glucose can be expected from doses above 3 gm daily. When good control has been achieved, the dose may be gradually reduced. An adequate blood glucose control may not be apparent until after 1-2 weeks. In order to minimize gastrointestinal side effects, Metformin HCl should be taken together with meals. Metformin HCl is usually given in two or three daily doses.

 d) Side Effects

Lactic acidosis, vitamin B12 and folate malabsorption, hypoglycemia, diarrhoea, skin reactions, other hypersensitivity reactions.

 e) Precautions and Warnings

Metformin should be used with caution to patients with hepatic and renal disease, elderly patients and cardiac failure.

 f) Contraindications

Impaired renal function, acute complications (severe infections, major operations and trauma), before X-ray examinations with iodinated contrast materials, liver damage, alcoholism, deficiencies of vitamin B12, folic acid and iron, ketosis prone diabetes, severe cardiovascular or respiratory disease, general ill health (malnutrition, dehydration, etc), diabetes with significant late complications (nephropathy, retinopathy).

 g)Drug Interactions

Phenprocoumon (increases elimination of phenprocoumon); Cimetidine (increases the availability of metformin and reduces its renal clearance, therefore, the dose of metformin should be reduced); Hyperglycemic agents (thiazides, corticosteroids may partly offset the antihyperglycemic action of metformin); Alcohol (alcohol potentiates the action of metformin)

 h)Use In Pregnancy and Lactation

Metformin- HCl may enter the breast milk and is best avoided in nursing mothers. Pregnancy is generally regarded as a contraindication, and insulin should be used in all pregnant diabetic women.

 i) Storage Conditions

• Store in a cool and dry place, protect from light.
• Keep out of the reach of children.

 j) Package Quantity

To be submitted at the time of inclusion.


www.dolphinpharmaltd.com-Copyright © 2009 - All rights reserved. Designed by: www.linuxoptic.com